300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
China
Andorra
Colombia
Sudan
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Canada
United Kingdom
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Gund Investment, LLC, VC Fund

Gund Investment, LLC

VC Fund

Princeton, United States

Gund Investment, LLC is a VC fund in Princeton focused on Medical and Health Care. Private investment firm of Gordon Gund, principal owner of Cleveland Cavaliers National Basketball Association team and member of Board of Governors of National Basketball Association, Cleveland Rockers Womens National Basketball Association franchise, San Jose Sharks National Hockey League team also principal owner and chairman of NationwideAdvertising Service, Inc. and director of Kellogg Company and Corning> Gund also prominent philanthropist, blind since 1970 from retinitis pigmentosa, co-founder with wife and chairman of The Foundation Fighting Blindness, leading private supporter of research focused on discovering causes, treatments, preventions and cures for retinitis pigmentosa, macular degeneration, Usher syndrome, and other retinal degenerative diseases> Investments include Align Technology, Silicon Valley company developed invisible alternative to orthodontic braces.

Total investments:
4
Last investment:
Lead investor:
25%

Last updated:

Industries Gund Investment, LLC invests in

MedicalHealth CareBiotechnologyMedical DeviceEyewear

Stages Gund Investment, LLC invests in

Series CFunding RoundVenture - Series Unknown

Countries Gund Investment, LLC invests in

United StatesIndia

Round sizes

Series C $10M–$17M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series C
$10M–$17M

Investment Focus

Industry

  • Medical 2 (50%)
  • Health Care 2 (50%)
  • Biotechnology 2 (50%)
  • Medical Device 2 (50%)
  • Eyewear 1 (25%)
See all 13 industries →

Stage

  • Series C 2 (50%)
  • Funding Round 1 (25%)
  • Venture - Series Unknown 1 (25%)

Country

  • United States 3 (75%)
  • India 1 (25%)

Team

NameTitleInvestmentsLinksEmail
Gordon Gund President
President Total investments: 0 Find email
Warren S. Thaler President
President Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Convergent Dental is a privately-owned dental equipment and technology company developing a computer-aided dental preparation system designed to offer a comfortable patient experience during dental surgeries. It is a carbon-dioxide laser for both hard and soft tissue indications that cuts quietly, finely, and faster than other laser-based systemsin dentistry using patented technologies and computer system controls. $5M / Venture - Series Unknown / Apr 24, 2023
ZoomIn, India's #1 online photo service, is about connecting people and their moments of magic. $8M / Aug 29, 2014
Bionano Genomics is a biotechnology company that specializes in genome mapping and analysis. The company develops and markets the Saphyr system, which is a platform for ultra-sensitive and ultra-specific structural variation detection in DNA. Structural variations are alterations in the DNA structure, such as insertions, deletions, inversions, andtranslocations, that can be associated with various genetic disorders and diseases, including cancer.Bionano Genomics' Saphyr system uses a technology called optical genome mapping (OGM) to analyze long DNA molecules. OGM allows for the direct visualization and analysis of structural variations in the genome without the need for sequencing. This technology can provide valuable insights into the structural variations in an individual's genome, which can be important for understanding disease mechanisms, and genetic disorders, and for guiding personalized treatment strategies. $10M / Series C / Oct 02, 2013
Ophthonix, Inc. manufactures and markets high resolution spectacle lenses for vision assessment and correction applications. It offers its high resolution lenses for single vision spectacle lenses for the correction of myopia, hyperopia, and mild astigmatism; and progressive addition spectacle lenses. The company sells its products throughpractitioners in the United States and European countries. Ophthonix, Inc. was founded in 2000 and is based in Vista, California. $17M / Series C / Oct 11, 2005

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
China
Andorra
Colombia
Sudan
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Canada
United Kingdom
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Gund Investment, LLC invest in?

Gund Investment, LLC invests primarily in Medical, Health Care and Biotechnology startups, most often at Series C and Funding Round stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Gund Investment, LLC's check size?

Gund Investment, LLC typically joins rounds of $10M–$17M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Gund Investment, LLC participates in.

How do I contact Gund Investment, LLC?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Gund Investment, LLC?

The team at Gund Investment, LLC includes Gordon Gund (President) and Warren S. Thaler (President). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Gund Investment, LLC Gund Investment, LLC Find emails